Clinical Trials · NCT07021937
Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
- Phase
- Phase 3
- Recruitment status
- Not Yet Recruiting
- Sponsor
- University of Colorado, Denver
- Enrollment
- 120
- Start date
- Jun 2026
- Locations
- 1 site, United States
- Primary endpoint
- blood oxygen-level dependent signal